The successful GMP manufacture of Shorla’s first sterile oncology product was recently completed via state of the art robotic filling technology in our European GMP accredited partner facility. We are grateful to have met this important milestone despite Covid-19 restrictions in support of our imminent license application to the US FDA for this life saving medicine for children in need.
